Vasomera, a stable, long-acting vasoactive intestinal peptide (VIP) agonist, targets G-protein-coupled VPAC2 receptors and is employed in the study of cardiomyopathy associated with dystrophinopathies [1].
CAS Number:
[1416067-68-9]
* VAT and and shipping costs not included. Errors and price changes excepted
